Por favor, use este identificador para citar o enlazar este ítem: https://www.arca.fiocruz.br/handle/icict/50733

Tipo
Artículo
Derechos de autor
Acceso abierto
Objetivos de Desarrollo Sostenible
08 Trabalho decente e crescimento econômico
Colecciones
Compartir

Estadísticas
Metadatos
Mostrar el registro completo del ítem

SCREENING FOR TUBERCULOSIS IN MIGRANTS: A SURVEY BY THE GLOBAL TUBERCULOSIS NETWORK
D’Ambrosio, Lia et al. | Fecha del documento: 2021
Autor
D’Ambrosio, Lia
Centis, Rosella
Dobler, Claudia C.
Tiberi, Simon
Matteelli, Alberto
Denholm, Justin
Zenner, Dominik
Al-Abri, Seif
Alyaquobi, Fatma
Arbex, Marcos Abdo
Belilovskiy, Evgeny Belilovskiy
Blanc, François-Xavier
Borisov, Sergey
Carvalho, Anna Cristina C.
Chakaya, Jeremiah Muhwa
Cocco, Nicola
Codecasa, Luigi Ruffo
Dalcolmo, Margareth Pretti
Dheda, Keertan
Dinh-Xuan, Anh Tuan
Esposito, Susanna R.
Garcia-Garcia, José Maria
Li, Yang
Manga, Selene
Marchese, Valentina
Torrico, Marcela Muñoz
Pontali, Emanuele
Rendon, Adrián
Silva, Denise Rossato
Singla, Rupak
Solovic, Ivan
Sotgiu, Giovanni
van den Boom, Martin
Nhung, Nguyen Viet
Zellweger, Jean-Pierre
Migliori, Giovanni Battista
Afiliación
Public Health Consulting Group. Lugano, Switzerland.
Istituti Clinici Scientifici Maugeri IRCCS. Clinica delle Malattie Respiratorie. Servizio di Epidemiologia. Tradate, Italy.
University of New South Wales. The George Institute for Global Health. Sydney, Australia / Department of Respiratory and Sleep Medicine, Liverpool Hospital. Sydney, Australia.
Royal London Hospital. Department of Infection. Barts Health NHS Trust. London, UK / Queen Mary University of London. Blizard Institute. London, UK.
Spedali Civili University Hospital. Division of Infectious and Tropical Diseases. Brescia, Italy / University of Brescia. WHO Collaborating Centre for TB/HIV Collaborative Activities and for TB Elimination Strategy. Brescia, Italy.
Victorian Tuberculosis Program, Melbourne Health. Melbourne, Australia / University of Melbourne. Peter Doherty Institute for Infection and Immunity. Department of Infectious Diseases. Melbourne, Australia / Royal Melbourne Hospital. Victorian Infectious Diseases Service. Melbourne, Australia.
Queen Mary University. Institute for Population Health Sciences. Centre for Global Public Health. London, UK.
Ministry of Health. Directorate General of Disease Surveillance and Control. Muscat, Oman.
Ministry of Health. Directorate General of Disease Surveillance and Control. Muscat, Oman.
Hospital Nestor Goulart Reis. Secretaria de Saúde do Estado de São Paulo. São Paulo, SP, Brasil / Universidade de Araraquara. Faculdade de Medicina. Araraquara, SP, Brasil.
Moscow Research and Clinical Center for Tuberculosis Control. Moscow, Russia.
Centre Hospitalier Universitaire, L’institut du Thorax. Service de Pneumologie. Nantes, France.
Moscow Research and Clinical Center for Tuberculosis Control. Moscow, Russia.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Inovações em Terapias, Ensino e Bioprodutos. Rio de Janeiro, RJ, Brasil.
Kenyatta University, Nairobi. Department of Medicine. Therapeutics, Dermatology and Psychiatry / Liverpool School of Tropical Medicine Department of Clinical Sciences. Liverpool, UK.
ASST Santi Paolo e Carlo—Medicina Penitenziaria. Milan. Italy.
Niguarda Hospital. TB Reference Centre. Villa Marelli Institute. Milan, Italy.
Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Centro de referência Helio Fraga. Rio de Janeiro, RJ, Brasil.
University of Cape Town. South African MRC Centre for the Study of Antimicrobial Resistance. Cape Town, South Africa / UCT Lung Institute, University of Cape Town. Centre for Lung Infection and Immunity. Division of Pulmonology. Department of Medicine. Cape Town, South Africa / London School of Hygiene and Tropical Medicine. Faculty of Infectious and Tropical Diseases. Department of Infection Biology. London, UK.
Cochin Hospital, Université de Paris. Department of Respiratory Medicine. Respiratory Physiology Unit. Paris, France.
University of Parma. University Hospital. Department of Medicine and Surgery. Paediatric Clinic. Parma, Italy.
Tuberculosis Research Programme SEPAR. Barcelona, Spain.
Fudan University. Huashan Hospital. Department of Infectious Diseases. Shanghai, China.
Ministry of Health. Direccion General de Gestion de Riesgos en y Desastres en Salud. Lima, Peru.
Division of Infectious and Tropical Diseases. Spedali Civili University Hospital. Brescia, Italy / University of Brescia. WHO Collaborating Centre for TB/HIV Collaborative Activities and for TB Elimination Strategy. Brescia, Italy.
Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas. Clínica de Tuberculosis. Mexico, Mexico.
Galliera Hospital. Department of Infectious Diseases. Genoa, Italy.
University Hospital of Monterrey UANL (Universidad Autonoma de Nuevo Leon). Centro de Investigación, Prevención y Tratamiento de Infecciones Respiratorias. Monterrey, Mexico.
Universidade Federal do Rio Grande do Sul. Faculdade de Medicina. Porto Alegre, RS, Brasil.
National Institute of TB & Respiratory Diseases. Department of TB & Respiratory Diseases. Sri Aurobindo Marg, New Delhi, India.
National Institute for TB, Vysne Hagy, Catholic University. Ruzomberok, Slovakia.
University of Sassari. Clinical Epidemiology and Medical Statistics Unit. Department of Medical, Surgical and Experimental Sciences. Sassari, Italy.
WHO Regional Office for the Eastern Mediterranean Region. Cairo, Egypt.
National Tuberculosis Programme. Hanoi, Vietnam.
TB Competence Center. Swiss Lung Association. Berne, Switzerland.
Istituti Clinici Scientifici Maugeri IRCCS. Clinica delle Malattie Respiratorie. Servizio di Epidemiologia. Tradate, Italy.
Resumen en ingles
Tuberculosis (TB) does not respect borders, and migration confounds global TB control and elimination. Systematic screening of immigrants from TB high burden settings and—to a lesser degree TB infection (TBI)—is recommended in most countries with a low incidence of TB. The aim of the study was to evaluate the views of a diverse group of international health professionals on TB management among migrants. Participants expressed their level of agreement using a six-point Likert scale with different statements in an online survey available in English, French, Mandarin, Spanish, Portuguese and Russian. The survey consisted of eight sections, covering TB and TBI screening and treatment in migrants. A total of 1055 respondents from 80 countries and territories participated between November 2019 and April 2020. The largest professional groups were pulmonologists (16.8%), other clinicians (30.4%), and nurses (11.8%). Participants generally supported infection control and TB surveillance established practices (administrative interventions, personal protection, etc.), while they disagreed on how to diagnose and manage both TB and TBI, particularly on which TBI regimens to use and when patients should be hospitalised. The results of this first knowledge, attitude and practice study on TB screening and treatment in migrants will inform public health policy and educational resources.
Palabras clave en portugues
Tuberculose
Migração
COVID-19
Gerenciamento de infecção por tuberculose
Prevenção
Controle de infecção
Triagem
Segurança no local de trabalho
 
Palabras clave en ingles
TB
Migration
COVID-19
TB infection management
Prevention
Infection control
Screening
Workplace safety
 
Editor
MDPI
Referencia
D´AMBROSIO, Lia et al. Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network. Antibiotics, v. 10, 1355, p. 1- 14, Nov. 2021.
DOI
10.3390/antibiotics10111355
ISSN
2079-6382